Stay updated on Risankizumab in Psoriatic Arthritis Clinical Trial

Sign up to get notified when there's something new on the Risankizumab in Psoriatic Arthritis Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Risankizumab in Psoriatic Arthritis Clinical Trial page

  1. Check
    7 days ago
    Change Detected
    Summary
    The study record for the Phase 3 risankizumab trial in active psoriatic arthritis is now displayed, including its eligibility criteria, design, outcomes, locations, and related publications and documents.
    Difference
    100%
    Check dated 2026-11-08T11:19:32.000Z thumbnail image
  2. Check
    14 days ago
    Change Detected
    Summary
    The site footer revision changed from v3.7.2 to v3.8.0 while the page continued to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-11-01T12:13:16.000Z thumbnail image
  3. Check
    21 days ago
    Change Detected
    Summary
    A site-wide notice says NIH websites are transitioning terminology from “Artificial Intelligence” to “Super Intelligence.”
    Difference
    1%
    Check dated 2026-10-25T12:21:00.000Z thumbnail image
  4. Check
    28 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov footer now identifies the site as revision v3.7.2 instead of v3.7.1. The page continues to display a 403 Forbidden error rather than the study record.
    Difference
    0.2%
    Check dated 2026-10-18T12:10:02.000Z thumbnail image
  5. Check
    34 days ago
    Change Detected
    Summary
    The footer revision number changes from v3.7.0 to v3.7.1 on the 403 error page.
    Difference
    0.2%
    Check dated 2026-10-11T13:31:46.000Z thumbnail image
  6. Check
    48 days ago
    Change Detected
    Summary
    The page now presents the complete study record with links to key PDFs and IPD sharing information, replacing the prior error and making the KEEPsAKE 2 details accessible.
    Difference
    100%
    Check dated 2026-09-27T19:43:17.000Z thumbnail image

Stay in the know with updates to Risankizumab in Psoriatic Arthritis Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Risankizumab in Psoriatic Arthritis Clinical Trial page.